Guardant Health Inc. (GH)
NASDAQ · Healthcare
Guardant Health Inc. EBITDA 2016–2025
Guardant Health Inc. annual/quarterly ebitda history and growth rate from 2016 to 2026. EBITDA stands for Earnings Before Interest, Taxes, Depreciation and Amortization. It is widely used as a measure of core operational profitability.
- Guardant Health Inc. ebitda for the quarter ending March 31, 2026 was -111.9 M, a 11.01% increase year-over-year.
- Guardant Health Inc. ebitda for the twelve months ending March 31, 2026 was -425.4 M, a 56.45% increase year-over-year.
- Guardant Health Inc. annual ebitda for 2025 was -397.5 M, a 0.92% decrease from 2024.
- Guardant Health Inc. annual ebitda for 2024 was -401.2 M, a 23.12% decrease from 2023.
- Guardant Health Inc. annual ebitda for 2023 was -521.8 M, a 2.64% increase from 2022.
- Guardant Health Inc. annual ebitda for 2022 was -508.4 M.
EBITDA
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Guardant Health Inc. EBITDA — FAQ
Guardant Health Inc. (GH) ebitda over the last 10 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see GH's ebitda history?
The chart and table above show Guardant Health Inc.'s ebitda by year and by quarter, including the growth rate.